Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated With Clinical Activity
{{output}}
Purpose: Tisotumab vedotin (TV) is a tissue factor (TF)-specific antibody-drug conjugate that was evaluated in the innovaTV 204 study in patients with recurrent or metastatic cervical cancer (r/mCC). Although TF expression is req... ...
